Promoting Quality in Drug Manufacturing

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-09-02-2004, Volume 28, Issue 9

FDA is re-engineering the CMC review process for innovator and generic drugs and backing risk-based ICH quality standards.

Related Content:

Process ValidationManufacturingQuality SystemsRegulatory WatchDevelopmentPharmaceutical Technology-09-02-2004
Shining a Light on Junior Pharmaceuticals
Managing mRNA Instability During Formulation, Manufacturing, and Shipment
The Power of PK/PD in mAb Development